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ABSTRAK
Kompleks tuberous sklerosis memiliki beberapa manifestasi di ginjal meliputi angiomiolipoma dan 
neoplasma epithelial renalis. Angiomiolipoma bilateral besar sangatlah jarang dijumpai. Kami melaporkan 
kasus angiomiolipoma bilateral besar dan mendiskusikan diagnosis dan manajemen kasus tersebut. Laki-laki 
usia 22 tahun masuk ke rumah sakit karena nyeri pinggang, hematuria, dan rasa penuh di perut. Pasien memiliki 
riwayat epilepsy, retardasi mental, dan gangguan perkembangan saat masa kanak-kanak. Pasien didiagnosis 
memiliki angiofibroma pada wajah sejak 10 tahun yang lalu. CT scan dan MRI abdomen iddapatkan massa besar 
berlobus-lobus yang memiliki densiteas heterogen bersesuaian dengan densitas lemak. Berdasarkan penemuan 
tersebut, kami mendiagnosis pasien dengan angiomiolipoma bilateral besar. Dilakukan manajemen konserfatif 
dan direncanakan nefrektomi total pada ginjal kira apabila perdarahan sangat masif. Angiomiolipoma yang 
disertai kompleks tuberous sclerosis biasanya bersifat multiple dan dapat tumbuh sangat besar. Angiomiolipoma 
bilateral besar, yang kasusnya sangat jarang, dapat ditatalaksana dengan terapi konserfatif apabila tidak 
dijumpai perdarahan yang signifikan.
Kata kunci: angiomiolipoma, terapi konserfatif, tuberous sclerosis kompleks.
ABSTRACT
Tuberous sclerosis complex (TSC) has several renal manifestations including angiomyolipomas (AML) and 
renal epithelial neoplasms. A bilateral giant renal AML is extremely rare. We report a case of giant bilateral 
AML and discuss the diagnosis and treatment of it. The 22-year-old man was admitted due to bilateral flank 
pain, gross hematuria, and abdominal fullness. He had history of epilepsy, mental retardation, and delayed 
development during childhood. He had angiofibroma on his face since 10 years ago. Abdominal CT and MRI 
revealed large lobulated heterogeneous mass with fatty content. Based on those findings, we diagnosed the 
patient with bilateral giant renal AML. We gave conservative management for the patient and planned to 
total nephrectomy on the left kidney if the continued bleeding occurred. AML associated with TSC occur more 
frequently as multiple lesions and grows to larger size than idiopathic AML. Bilateral giant AML, which is very 
rare, could be treated with conservative management if no significant hemorrhage occurred. 
Keywords: angiomyolipoma, tuberous sclerosis complex, conservative management.
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INTRODUCTION
Tuberous sclerosis  complex (TSC) 
has several renal manifestations including 
angiomyolipomas (AML) and renal epithelial 
neoplasms.1 AML occured in 0.3% of population 
and comprised 3% of the solid renal mass.2 
AML associated with TSC affects with greater 
frequency between second and third decade. 
The TSC is characterized by a clasical triad 
of epilepsy, mental retardation, and sebaceous 
adenoma.3-5 Although AML of kidney is a benign 
lesion, it shows a rapid growth with a significant 
morbidity because of the the risk of rupture 
leading to profuse retroperitoneal bleeding.6 The 
management is much dependent on tumor size.7
A bilateral giant renal angiomyolipoma is 
extremely rare. Six cases were published in 
previous papers which vary in tumor weight, 
from 3750 g until 5800 g, and treatment. We 
report a case of giant bilateral AML and discuss 
the diagnosis and treatment of this case.
CASE ILLUSTRATION
Male, 22 years old, was admitted to our 
hospital due to gross hematuria, left and right 
flank pain. The patient felt abdominal distention 
on his left and right abdomen one year before 
admission. The patient had a history of epilepsy, 
delayed development, and learning difficulties 
during childhood. Patient had a multiple 
papule and nodule on his face since 3 years old 
suggestive angiofibroma. There was no family 
history of TSC.
Physical examination revealed hypertension, 
tachycardia, and palpated bilateral mass in 
upper quadrant abdomen with costo-vertebral 
knocking pain. There were multiple hyper-
pigmented papules and nodules on his face. 
Laboratory studies revealed anemia (Hb=7.2 g/
dl), leukocytosis (white blood counts 14.300/ul), 
and blood creatinin of 1.6 mg/dl.
An abdominal CT showed right renal contour 
with multiple lobulated with heterogeneous 
density, -62 to 30 Hounsfield Unit (HU). Right 
pelviocalyx system did not clearly show. A 
large mass was filled the entire left abdomen 
with heterogeneous density, -78 to 60 HU. 
An abdominal MRI showed large lobulated 
heterogeneous mass with fatty content in entire 
left abdomen with volume of 15.2 x 17.1 x 
30 cm in accordance with AML. A picture of 
normal left kidney did not exist. There were 
multiple lobulated heterogeneous masses with 
fatty content in right kidney in accordance with 
AML in right kidney. Two large masses in right 
kidney were at upper pole with volume of 8.2 x 
5.4 x 5.2 (cm3) and in lower pole with volume 
of 7.5 x 4.8 x 7.1(cm3).
The patient was diagnosed with bilateral 
giant renal AML and TSC. We performed blood 
evacuation in the bladder and performed bladder 
irrigation with three-way foley catheter. The 
patient had blood transfusion with packed red 
cell (PRC) because of recurrent gross hematuria. 
A total 9 bag of PRC was transfused in 6 months 
of follow up. Arterial embolization or surgery 
was not performed because we considered the 
bilateral tumor in the patient kidney. Afterwards, 
the condition of the patient was stable with 
Figure 1. Facial angiofibroma
Figure 2. Abdominal CT shows fatty content in entire left 
abdomen (big arrow) and multilobulated fatty content in right 
kidney (small arrow)
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no gross hematuria. However, if the bleeding 
continued and was very massive, we had planned 
to perform total nephrectomy on left kidney.
50% patients, respectively.1 AML associated 
with TSC occurs more frequently as multiple 
lessions and grows to larger size than idiopathic 
AML and shows a significant higher likelihood of 
rupture causing a hemorrhagic shock secondary 
to hematuria or retroperitoneal bleeding. Hence, 
patients with AML without TSC, the tumor is 
generally asymptomatic and single.6
TSC is caused by mutations in either the 
TSC 1 gene located in chromosome 9 or TSC 2 
gene located in chromosome 16. Children with 
TSC gene are born with normal kidney but they 
will develop renal cyst and AML as they age. 
Both renal cyst and AML can cause chronic 
kidney disease as leading cause of death in adult 
patients.8 Mortality and morbidity of AML is 
associated with the risk of hemmorrhage and the 
invasion of the lession to adjacent normal renal 
parenchyma leading to chronic kidney disease 
and even end-stage renal disease.
Most AML are benign and asymptomatic 
unless the tumor size reaches 4 cm or more. 
Lenk’s triad including flank pain (53%), a 
palpable tender mass (47%), and gross hematuria 
(23%) are a classic symptoms in patients with 
tumor size more than 4 cm.9 Other posible 
symptoms and sign are hemorrhage, hematuria, 
palpable mass, nausea and vomiting, systemic 
arterial hypertension, anemia, fever, shock, 
and urinary tract infection.10 Smaller lesions, 
defined as being less than 4 cm, can present with 
microhematuria or chronic mild flank pain. It 
is usually asymptomatic and often discovered 
accidentally by Ultrasonography or CT-Scan.11 In 
our case, we found our patient with a huge tumor 
sized, more than 8 cm. Clinical manifestation 
was anemia due to gross hematuria. He had also 
flank pain, and palpable mass in left and right 
abdomen. Thus, our patient was diagnosed by 
TSC because the clasical Vogt’s triad symptoms 
were present including hystory of epilepsi, 
mental retardation, and facial angiofibroma.
AML is the only benign renal tumor 
diagnosed on cross-sectional imaging. The 
presence of fat, confirmed by a negative 
attenuation values of -25 HU or less in CT, 
within a renal lesion is considered the diagnostic 
hallmark.12 Findings of more than 20 pixels with 
attenuation -20 HU or less and of more than 5 
Figure 3. Abdominal MRI shows large lobulated fatty mass 
in entire lift abdomen
Figure 4. Fatty content in upper pole of the right kidney was 
showed on abdominal MRI
DISCUSSION
TSC is a congenital disease related to 
autosomal dominant that characterized by the 
presence of clasical Vogt’s triad symptoms 
including intractable epilepsy, mental retardation, 
and facial angiobiromas.3-5 However, less than 
40% of affeted patients have all three feautures. 
Renal AMLs, cardiac rhabdomyomas, pancreatic 
cysts, fibroadenoma sebaceous, and brain nodules 
may be associated with TSC. The most common 
TSC manifestation is neurologic symptoms 
including 90% of patients experience seizures 
and about 50% of patients experience cognitive 
impairment, autism, and other behavioral 
disorders. The second most common of TSC 
manifestation is renal manifestation which is 
AML and renal cysct that found in 80% and 
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pixels with attenuation less than -30 HU hava a 
100% of positive predictive value. MRI can be 
used in difficult cases or with CT scan, with the 
findings of fat images are being sugestive of the 
diagnosis of AML.13 Doubtful diagnosis persists 
in the case which there is little fat content in the 
tumor or the presence of previous bleeding which 
conceal the fat content. The CT of our patient 
suggests the heterogenous density from -78 to 60 
HU. The presecence of -30 HU suggests 100% of 
predictive value for diagnosing the AML.
Management of the AML is very related 
to the clinical presentation, tumor size, 
single or multiple lessions, and potential of 
malignancy.7 The asymptomatic patients treat 
with conservative management, with regular 
clinical and radiological follow up. For those 
patients with pain, heamorage, complex lessions, 
and enlarging tumors, nephorn sparing surgery 
and/or intra-arterial embolization are considered 
to have better outcome. Current recomendations 
are to obtain US at initial diagnosis and then 
every 1-3 years based on tumor burden.14 
Symptomatic tumors with tumor sized more 
4 cm should undergo angiographic evaluation 
with either partial nephrectomy or arterial 
embolization. Asymptomatic tumors, sized more 
than 4 cm should repeat US or other imaging 
modalities every 6 months. Symptomatic tumors 
sized less than 4 cm should be observed for tumor 
resolution, but if no resolution is observed, partial 
nephrectomy or elective arterial embolization is 
the selected treatment. Asymptomatic tumor 
<4 cm should be monitored routinely every 1 
to 3 years.15,16 AML greater than 8 cm should 
be managed surgically for preventing the 
complications such as haemorage and rupture. 
However, if the tumors are bilateral, the option 
for treatment become a problem.
The principles of managemet for bilateral 
AML, which is a benign nature, are resolution 
of symptoms and prevention of fatal morbidity 
without comprising renal function.17,18 Selective 
arterial embolization and/or nephron-sparing 
surgery are renal preserving modalities for the 
patients with bilateral tumor.19 In patient with 
solitary kidney who suffering AML, selective 
arterial embolization is recomended. Hence, a 
risk for unexpected large ischemia should be 
considered when treating the tumor with multiple 
feeding arteries.19,20 Nephron-sparing surgery 
preserves as much renal parenchyma as possible 
and therefore, these benign lesions should be 
treated with this method whenever possible.19
Huge bilateral renal angiomyolipoma is 
extremely rare. Six cases were reported with 
different tumor burden from 3200 g to 5800 
gram and different modalities of treatment 
were applied based on the patient condition, 
tumor burden, and the prescence of acute 
hemorage. Shen et al21 reported bilateral 
huge angiomyolipoma treated with unilateral 
nephrectomy. Cakan et al22 reported a good result 
by doing bilateral nephorn-sparing surgery based 
on the characteristic of tumor which showed 
multiple lobulated tumor lessions in the both 
kidney. Katayama et al23 performed unilateral 
nephrectomy folowed by routine hemodialysis 
because from imaging modalities showed 
internal haemorrhage. Hussain et al24 reported 
bilateral nephrectomy with co-existing AML 
and renal cell carcinoma which is very rare. The 
patient was susbsequently transplanted and no 
reccurence or metasteses of rencal cell carcinoma 
in the follow-up. Kobayashi et al25 reported a 
bilateral massive renal AML with hemorrhagic 
shock who underwent selective transarterial 
embolization followed by bilateral nephrectomy. 
The total tumor burden weighed 5800 g, making 
the largerst AML by weight in published reports. 
The postoperative course was uneventfull and 
permanent hemodialysis was attempted. Ciancio 
et al26 reported a bilateral giant AML with acute 
hemorage in unilateral kidney treated with 
artery embolization and total nephrectomy. The 
contralateral tumor was removed with partial 
nephrectomy to preserve renal function.
Our patient was considered to have 
conservative management with routine follow 
up for the presence of significant hemorrhage. 
On the last follow up, no hemorrhage observed 
by ultrasonography in the both of kidney. We 
were neither considered arterial embolization 
nor surgery because the presence of bilateral 
tumor without significant hemorrhage. However, 
we plan to do nephrectomy in left kidney if 
significant hemorrhage is occured.
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CONCLUSION
AML associated with TSC occurs more 
frequently as multiple lessions and grows larger 
size than idiopathic AML. Bilateral giant renal 
angiomyolipoma, which is very rare, can be 
treated with conservative management if no 
significant hemmorage occured.
REFERENCES
1. Dixon BP, Hulbert JC, Bissler JJ. Tuberous sclerosis 
complex renal disease. Nephron Exp Nephrol. 
2010;118(1):e15-e20.
2. Nelson CP, Sanda MG. Contemporary diagnosis 
and management of renal angiomyolipoma. J Urol. 
2002;168(4 Pt 1):1315-25.
3. Curton P. Tuberous sclerosis complex: From basic 
science to clinic phenotypes. London: Mac Keith Press; 
2003.
4. Crino PB, Nathanson KL, Henske EP. The tuberous 
sclerosis complex. N Eng J Med. 2006;355(13):1345-
56.
5. Yates JR. Tuberous sclerosis. Eur J Hum Genet. 
2006;14(10):1065-73.
6. Bissler JJ, Kingswood JC. Renal angiomyolipomata. 
Kidney International. 2004;66:924-34.
7. Al-Thani H, El-Menyar A, Al-Sulaiti M, et al. Clinical 
presentation, management, and outcome of patients 
with incidental renal angiomyolipoma in Qatar. Oman 
Med J. 2014;29(6):419-24.
8. Dabora SL, Joswiak S, Franz DN, et al. Mutational 
analysis in a cohort of 224 tuberous sclerosis patients 
indicates increased severity of TSC2, compared with 
TSC1, disease in multiple organ. Am J Hum Genet. 
2001;68(1):64-80.
9. Simmons JL, Hussain SA, Riley P, Wallace DM. 
Management of renal angiomyolipoma in patients 
with tuberous sclerosis complex. Oncol Rep. 
2003;10(1):237-41.
10. Schneider-Monteiro ED, Lucon AM, Figueiredo 
AAd, Junior AJR, Arap S. Bilateral giant renal 
angiomyolipoma associated with hepatic lipoma in 
a patient with tuberous sclerosis. Rev Hosp Clin. 
2003;58(2):103-8.
11. Berglund RK, Bernstein M, Manion MT, Touijer KA, 
Russo P. Incidental angiomyolipoma resected during 
renal surgery for an enhancing renal mass. BJU Int. 
2009;104(11):1650-4.
12. Ryan MJ, Francis IR, Cohan RH, et al. Imaging 
appearance of renal epithelioid angiomyolipomas. J 
Comput Assist Tomogr. 2013;37(6):957-61.
13. Simpfendrorfer C, Herts BR, Motta-Ramirez GA, et 
al. Angiomyolipoma with minimal fat on MDCT: can 
counts of negative-attenuation pixels aid diagnosis? 
AJR Am J Roentgenol. 2009;192(2):438-43.
14. Hyman MH, Whittemore VH. National instituse 
of health consensus confrence: tuberous sclerosis 
complex. Arch Neurol. 2000;57(5):662-5.
15. Winterkorn EB, Daouk GH, Anupindi S, Thiele EA. 
Tuberous sclerosis complex and renal angiomyolipoma: 
case report and review of the literature. Pediatr 
Nephrol. 2006;21:1189-93.
16. Park HK, Zhang S, Wong MK, Kim HL. Clinical 
presentation of epitheloid angiomyolipoma. Int J Urol. 
2007;14(1):21-5.
17. Chan SY, Chan WKY. Huge renal angiomyolipomas 
in tuberous sclerosis complex. Nephrology. 
2005;10(4):382-6.
18. Harabayashi T, Shinora N, Katano H, Nonomura 
K, Shimizu T, Koyanagi T. Management of renal 
angiomyolipomas associated with tuberous sclerosis 
complex. J Urol. 2004;171(1):102-5.
19. Boorijan SA, Frank I, Inman B, Lohse CM, Cheville 
JC, Blute ML. The role of partial nephrectomy of 
management of sporadic renal angiomyolipoma. 
Urology. 2007;70(6):1064-8.
20. Koike H, Muller SC, Hohenefellner R. Management of 
renal angiomyolipoma: a report of 14 cases and review 
of the literature. Is nonsurgical treatment adequate for 
this tumor? Eur Urol. 1994;25(3):183-8.
21. Shen C-H, Tung C-L, Yan Y-H, Cheng M-C. Huge 
bilateral renal angiomyolipoma. BMJ Case Rep. 2013; 
doi:10.1136/bcr-2012-007418.
22. Cakan M, Demirel F, Yalcinkaya F, Altug U. Bilateral 
nephron-sparing surgery for giant bilateral renal 
angiomyolipomas associated with tuberous sclerosis 
complex. J Ankara Univ Fac Med. 2006;59:83-5.
23. Katayama K, Hayashi T, Tsutahara K, Matsuoka 
A, Fujimoto N, Koide T. Bilateral giant renal 
angiomyolipoma following hemodialysis in a patient 
with tuberous sclerosis. Acta Urol Jpn. 2009;55:335-8.
24. Hussain M, Mubarak M, Sultan G,  et al. Renal 
transplant in a tuberous sclerosis patient with 
bilateral giant renal angiomyolipomas and concurent 
renal carcinoma. Saudi J Kidney Dis Transpl. 
2013;24(2):318-21.
25. Kobayashi M, Nakano K, Nukui A, Goto K, Morita T. 
Bilateral massive renal angiomyolipoma concurrent 
with oncocytoma in tuberous sclerosis complex 
associated with pulmonary lymphangioleiomyomatosis. 
Urology. 2008;72(948):e7-9.
26. Ciancio SJ, Vira M, Simon MA, Lerner SP, Schulam 
PG. Giant bilateral renal angiomyolipomas associated 
with tuberous sclerosis. Urology. 2001;57:554i-ii. 
